Solventum (NYSE:SOLV) today announced plans to separate its Health Information Systems business as part of its portfolio optimization strategy.
The company — a spinoff itself from the one-time 3M Health Care business — intends to evaluate a range of separation pathways. Eagan, Minnesota-–based Solventum said it aims to maximize shareholder value and position the company and its soon-to-be-separated business for long-term success.
According to Solventum, the announcement marks the latest step in its broader three-phase transformation strategy. The company already sold off its Purification & Filtration (P&F) business to Thermo Fisher Scientific last year. It said its board believes separating this business can help transform the company into a more dedicated medtech company.
Health Information Systems, a healthcare software business, generates $1.4 million in annual sales. Its solutions, which feature a proprietary rules engine, extensive data assets and AI-driven autonomous coding capabilities are deployed across more than 30 countries and used by more than 75% of U.S. hospitals, the company says.
With the separation of Health Information Systems, Solventum expects to sharpen its focus on its MedSurg and Dental Solutions businesses. It expects that a more focused portfolio can position the company to accelerate innovation, enhance commercial execution and deliver sustainable long-term growth.
Solventum targets completion of a separation within 12-18 months. Potential structures include separating the unit as an independent company, combined with a scaled player or in another transaction.
“We have moved with urgency to advance portfolio optimization, a core pillar of our transformation strategy,” said Bryan Hanson, CEO of Solventum. “Health Information Systems is a differentiated business with a strong position and significant potential. We believe separation can unlock value by enabling both businesses to pursue distinct growth agendas, accelerate innovation and realize their full potential.”
